6505--RX - OUTSOURCED CHEMOTHERAPY COMPOUNDING 36C24226Q0550
Summary
AI-generated · Apr 21, 2026Outsourced chemotherapy compounding services are being pursued through a sole-source procurement, per a Special Notice of Intent to Sole Source. The requirement covers external preparation of chemotherapy medications (compounding) rather than in-house production. The notice provides no detailed qualifications, submission instructions, or competitive process, and there is no award date or amount yet, indicating this is in an early planning stage.
Notice of Intent to Sole Source
From Special Notice posted on Apr 20, 2026Notice history
1Details
Award Information
Contacts
Contracting Officer
Phone